Neil Tanday

452 total citations
28 papers, 342 citations indexed

About

Neil Tanday is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Neil Tanday has authored 28 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 21 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Neil Tanday's work include Pancreatic function and diabetes (22 papers), Diabetes Treatment and Management (15 papers) and Neuropeptides and Animal Physiology (10 papers). Neil Tanday is often cited by papers focused on Pancreatic function and diabetes (22 papers), Diabetes Treatment and Management (15 papers) and Neuropeptides and Animal Physiology (10 papers). Neil Tanday collaborates with scholars based in United Kingdom, Sweden and Germany. Neil Tanday's co-authors include Peter R. Flatt, Nigel Irwin, R. Charlotte Moffett, Ryan A. Lafferty, Frank Reimann, Fiona M. Gribble, Victor A. Gault, Andrei I. Tarasov, Finbarr O’Harte and Pradeep Bompada and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Neil Tanday

27 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Tanday United Kingdom 13 240 227 108 93 82 28 342
Christopher Bannon United Kingdom 5 153 0.6× 168 0.7× 45 0.4× 46 0.5× 97 1.2× 11 346
T. Iványi Hungary 13 116 0.5× 328 1.4× 52 0.5× 22 0.2× 147 1.8× 22 488
Eckart Bartels Germany 2 217 0.9× 382 1.7× 33 0.3× 88 0.9× 137 1.7× 3 433
Burkhard Göke Germany 7 255 1.1× 409 1.8× 37 0.3× 94 1.0× 129 1.6× 11 550
Silke A. Herzberg-Schäfer Germany 7 86 0.4× 92 0.4× 62 0.6× 20 0.2× 77 0.9× 7 238
Scott A. Segel United States 3 171 0.7× 299 1.3× 137 1.3× 20 0.2× 37 0.5× 4 363
G. B. Bolli Italy 8 256 1.1× 502 2.2× 126 1.2× 13 0.1× 110 1.3× 19 530
Wanda L. Snead United States 12 190 0.8× 176 0.8× 36 0.3× 19 0.2× 101 1.2× 12 385
Birgitte Hylleberg Denmark 6 466 1.9× 777 3.4× 257 2.4× 29 0.3× 133 1.6× 8 809
Davide Gallo Italy 11 143 0.6× 94 0.4× 56 0.5× 42 0.5× 112 1.4× 21 490

Countries citing papers authored by Neil Tanday

Since Specialization
Citations

This map shows the geographic impact of Neil Tanday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Tanday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Tanday more than expected).

Fields of papers citing papers by Neil Tanday

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Tanday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Tanday. The network helps show where Neil Tanday may publish in the future.

Co-authorship network of co-authors of Neil Tanday

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Tanday. A scholar is included among the top collaborators of Neil Tanday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Tanday. Neil Tanday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanday, Neil, et al.. (2025). The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage. International Journal of Molecular Sciences. 26(9). 4215–4215. 2 indexed citations
2.
Dubey, Vaibhav, Neil Tanday, Andrei I. Tarasov, et al.. (2025). Effect of Multiparity on Pregnancy-Induced Islet Adaptation and Cellular Transdifferentiation. Clinical Medicine Insights Endocrinology and Diabetes. 18. 753245452–753245452.
3.
Dubey, Vaibhav, Neil Tanday, Nigel Irwin, et al.. (2024). Cafeteria diet compromises natural adaptations of islet cell transdifferentiation and turnover in pregnancy. Diabetic Medicine. 42(1). e15434–e15434. 2 indexed citations
6.
Tanday, Neil, et al.. (2023). A novel peptide isolated from Aphonopelma chalcodes tarantula venom with benefits on pancreatic islet function and appetite control. Biochemical Pharmacology. 212. 115544–115544. 4 indexed citations
7.
Tanday, Neil, et al.. (2023). Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice. Journal of Endocrinology. 259(2). 5 indexed citations
8.
Tanday, Neil, Andrei I. Tarasov, R. Charlotte Moffett, Peter R. Flatt, & Nigel Irwin. (2023). Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?. Diabetes Obesity and Metabolism. 26(1). 16–31. 14 indexed citations
9.
Tanday, Neil, et al.. (2023). Sustained metabolic benefits of ΔTRTX‐Ac1 , a tarantula venom‐derived peptide, when administered together with exenatide in high‐fat fed mice. Diabetes Obesity and Metabolism. 26(1). 329–338. 2 indexed citations
10.
Lafferty, Ryan A., Neil Tanday, Vaibhav Dubey, et al.. (2023). The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(Lys12PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia. Molecular and Cellular Endocrinology. 570. 111932–111932. 2 indexed citations
11.
Tanday, Neil, et al.. (2022). Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes. Peptides. 160. 170923–170923. 21 indexed citations
12.
Tanday, Neil, Ryan A. Lafferty, Peter R. Flatt, & Nigel Irwin. (2022). Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists. Diabetes Obesity and Metabolism. 24(12). 2353–2363. 11 indexed citations
13.
Tanday, Neil, Peter R. Flatt, & Nigel Irwin. (2021). Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands. British Journal of Pharmacology. 179(4). 526–541. 28 indexed citations
15.
Tanday, Neil, R. Charlotte Moffett, Victor A. Gault, Peter R. Flatt, & Nigel Irwin. (2020). Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1Cre/+;Rosa26‐eYFP mice. Diabetes/Metabolism Research and Reviews. 37(3). e3384–e3384. 9 indexed citations
16.
Tanday, Neil, Nigel Irwin, R. Charlotte Moffett, Peter R. Flatt, & Finbarr O’Harte. (2020). Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation. Diabetes Obesity and Metabolism. 22(12). 2468–2478. 24 indexed citations
17.
Moffett, R. Charlotte, Neil Tanday, Frank Reimann, et al.. (2020). Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiation. Biochemical Pharmacology. 182. 114216–114216. 17 indexed citations
18.
Moffett, R. Charlotte, Victor A. Gault, Neil Tanday, et al.. (2019). Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice. Peptides. 125. 170205–170205. 26 indexed citations
19.
Lafferty, Ryan A., Neil Tanday, Pradeep Bompada, et al.. (2019). Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β‐cell function, growth and survival. Diabetes Obesity and Metabolism. 22(3). 404–416. 22 indexed citations
20.
Hasib, Annie, et al.. (2018). Exendin‐4(Lys27PAL)/gastrin/xenin‐8‐Gln: A novel acylated GLP‐1/gastrin/xenin hybrid peptide that improves metabolic status in obese‐diabetic (ob/ob) mice. Diabetes/Metabolism Research and Reviews. 35(3). e3106–e3106. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026